PRISMA HEALTH BAPTIST HOSPITAL
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $1.5M
- Transactions
- 230
- Companies
- 22
- Average per transaction
- $6,388
Who reported the payments
| Gilead | $655,405 |
| Endotronix, Inc. | $462,140 |
| Ascendis Pharma Endocrinology Inc | $64,415 |
| Medical Device Business Services, Inc. | $52,192 |
| Janssen Research & Development, LLC | $44,662 |
| Medtronic | $39,569 |
| Novartis | $39,306 |
| Abbott | $24,751 |
| Biotronik Inc. | $21,691 |
| Zimmer Biomet | $18,939 |
| Biomarin Pharmaceutical Inc. | $18,582 |
| Johnson & Johnson | $6,807 |
| Agfa Healthcare Corporation | $5,573 |
| Aesculap Implant Systems, LLC | $3,996 |
| Takeda Pharmaceuticals U.S.A., Inc. | $3,394 |
| Integra Lifesciences Corporation | $3,000 |
| Amryt Pharma Holdings Ltd | $2,466 |
| BD | $1,485 |
| Welch Allyn | $589 |
| CMS Imaging, Inc. | $166 |
| Mizuho America, Inc. | $70 |
| Olympus America Inc. | $19 |